The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Gene Therapy with Brain-Derived Neurotrophic Factor As a Protection: Retinal Ganglion Cells in a Rat Glaucoma Model
Abstract
PURPOSE: To develop a modified adenoassociated viral (AAV) vector capable of efficient transfection of retinal ganglion cells (RGCs) and to test the hypothesis that use of this vector to express brain-derived neurotrophic factor (BDNF) could be protective in experimental glaucoma. METHODS: Ninety-three rats received one unilateral, intravitreal injection of either normal saline (n = 30), AAV-BDNF-woodchuck hepatitis posttranscriptional regulatory element (WPRE; n = 30), or AAV-green fluorescent protein (GFP)-WPRE (n = 33). Two weeks later, experimental glaucoma was induced in the injected eye by laser application to the trabecular meshwork. Survival of RGCs was estimated by counting axons in optic nerve cross sections after 4 weeks of glaucoma. Transgene expression was assessed by immunohistochemistry, Western blot analysis, and direct visualization of GFP. RESULTS: The density of GFP-positive cells in retinal wholemounts was 1,828 +/- 299 cells/mm(2) (72,273 +/- 11,814 cells/retina). Exposure to elevated intraocular pressure was similar in all groups. Four weeks after initial laser treatment, axon loss was 52.3% +/- 27.1% in the saline-treated group (n = 25) and 52.3% +/- 24.2% in the AAV-GFP-WPRE group (n = 30), but only 32.3% +/- 23.0% in the AAV-BDNF-WPRE group (n = 27). Survival in AAV-BDNF-WPRE animals increased markedly and the difference was significant compared with those receiving either AAV-GFP-WPRE (P = 0.002, t-test) or saline (P = 0.006, t-test). CONCLUSIONS: Overexpression of the BDNF gene protects RGC as estimated by axon counts in a rat glaucoma model, further supporting the potential feasibility of neurotrophic therapy as a complement to the lowering of IOP in the treatment of glaucoma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AAV vector delivery via intravitreal (IVT) injection is a minimally invasive procedure that offers the potential for broad inner retinal transduction, providing significant transgene expression in the ganglion cell layer (GCL) (10, 14–17), and in particular in retinal ganglion cells (RGCs) (17–20).”
From Intravitreal AAV vector delivery induces integrin-dependent ocular inflammation, complement activation, and antiviral and DNA damage responses (2026) · cites this paper as [20]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Kass, M. A. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.6.701 · Cited by 3,705
Heijl, A. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.10.1268 · Cited by 3,320
Number of people with glaucoma worldwide.
Quigley, H. A. (1996) · British Journal of Ophthalmology · doi:10.1136/bjo.80.5.389 · Cited by 2,998
Self-citation(1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(98)00223-2 · Cited by 1,599
Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
Astrocyte glutamate transport: Review of properties, regulation, and physiological functions
Anderson, C. M., & Swanson, R. A. (2000) · Glia · doi:10.1002/1098-1136(200010)32:1<71::aid-glia70>3.0.co;2-0 · Cited by 1,242
Gene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202
Self-citationSommer, A. (1991) · Archives of Ophthalmology · doi:10.1001/archopht.1991.01080080050026 · Cited by 1,178
Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis.
Quigley, H. A., Nickells, R. W., Kerrigan, L. A., Pease, M. E., Thibault, D., & Zack, D. J. (1995) · PubMed · Cited by 935
Self-citationKerrigan, L. A., Quigley, H. A., Pease, M. E., Kerrigan, D., & Mitchell, R. S. (2000) · PubMed · Cited by 869
Self-citationDiStefano, P. S., Friedman, B., Radziejewski, C., Alexander, C., Boland, P., Schick, C. M., Lindsay, R. M., & Wiegand, S. J. (1992) · Neuron · doi:10.1016/0896-6273(92)90213-w · Cited by 742
Mansour-Robaey, S., Clarke, D. B., Wang, Y. C., Bray, G. M., & Aguayo, A. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1632 · Cited by 731
Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors
Grimm, D., Kern, A., Rittner, K., & Kleinschmidt, J. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2745 · Cited by 696
Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma.
Pease, M. E., McKinnon, S. J., Quigley, H. A., Kerrigan, L. A., & Zack, D. J. (2000) · PubMed · Cited by 524
Self-citationA Rat Model of Chronic Pressure-induced Optic Nerve Damage
MORRISON, J. C., MOORE, C. G., DEPPMEIER, L. M. H., GOLD, B. G., MESHUL, C. K., & JOHNSON, E. C. (1997) · Experimental Eye Research · doi:10.1006/exer.1996.0184 · Cited by 519
Quigley, H. A., McKinnon, S. J., Zack, D. J., Pease, M. E., Kerrigan, L. A., Kerrigan, D., & Mitchell, R. S. (2000) · PubMed · Cited by 491
Self-citationTUNEL-Positive Ganglion Cells in Human Primary Open-angle Glaucoma
Kerrigan, L. A. (1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100160201010 · Cited by 465
Programmed cell death of retinal ganglion cells during experimental glaucoma
Garcia-Valenzuela, E., Shareef, S., Walsh, J., & Sharma, S. C. (1995) · Experimental Eye Research · doi:10.1016/s0014-4835(95)80056-5 · Cited by 463
Di Polo, A., Aigner, L. J., Dunn, R. J., Bray, G. M., & Aguayo, A. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3978 · Cited by 430
Neuroprotection in Relation to Retinal Ischemia and Relevance to Glaucoma
Osborne, N. N., Ugarte, M., Chao, M., Chidlow, G., Bae, J. H., Wood, J. P. M., & Nash, M. S. (1999) · Survey of Ophthalmology · doi:10.1016/s0039-6257(99)00044-2 · Cited by 404
A generic intron increases gene expression in transgenic mice.
Choi, T., Huang, M., Gorman, C., & Jaenisch, R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.6.3070 · Cited by 356
Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element
Donello, J. E., Loeb, J. E., & Hope, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5085-5092.1998 · Cited by 350
Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats.
Levkovitch-Verbin, H., Quigley, H. A., Martin, K. R. G., Valenta, D. F., Baumrind, L. A., & Pease, M. E. (2002) · PubMed · Cited by 320
Self-citationAli, R. R., Sarra, G.-M., Stephens, C., Alwis, M. D., Bainbridge, J. W. B., Munro, P. M., Fauser, S., Reichel, M. B., Kinnon, C., Hunt, D. M., et al. (2000) · Nature Genetics · doi:10.1038/77068 · Cited by 304
Loeb, J. E., Cordier, W. S., Harris, M. E., Weitzman, M. D., & Hope, T. J. (1999) · Human Gene Therapy · doi:10.1089/10430349950016942 · Cited by 279
TrkB Gene Transfer Protects Retinal Ganglion Cells from Axotomy-Induced Death In Vivo
Cheng, L., Sapieha, P., Kittlerová, P., Hauswirth, W. W., & Di Polo, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-03977.2002 · Cited by 254
Self-citationApoptosis of Retinal Ganglion Cells in Glaucoma
Nickells, R. W. (1999) · Survey of Ophthalmology · doi:10.1016/s0039-6257(99)00029-6 · Cited by 232
Liang, F.-Q., Aleman, T. S., Dejneka, N. S., Dudus, L., Fisher, K. J., Maguire, A. M., Jacobson, S. G., & Bennett, J. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0473 · Cited by 222
Yücel, Y. H., Zhang, Q., Weinreb, R. N., Kaufman, P. L., & Gupta, N. (2001) · PubMed · Cited by 214
Retinal Ganglion Cells Lose Trophic Responsiveness after Axotomy
Shen, S., Wiemelt, A. P., McMorris, F. A., & Barres, B. A. (1999) · Neuron · doi:10.1016/s0896-6273(00)80780-1 · Cited by 207
Paterna, J.-C., Moccetti, T., Mura, A., Feldon, J., & Büeler, H. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301221 · Cited by 189
Klöcker, N., Kermer, P., Weishaupt, J. H., Labes, M., Ankerhold, R., & Bähr, M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06962.2000 · Cited by 185
RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection.
Levkovitch-Verbin, H., Harris-Cerruti, C., Groner, Y., Wheeler, L. A., Schwartz, M., & Yoles, E. (2000) · PubMed · Cited by 177
Self-citationAdeno-associated virus vectors: activity and applications in the CNS
Peel, A. L., & Klein, R. L. (2000) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(00)00183-7 · Cited by 174
Self-citationBDNF Injected into the Superior Colliculus Reduces Developmental Retinal Ganglion Cell Death
Ma, Y.-T., Hsieh, T., Forbes, M. E., Johnson, J. E., & Frost, D. O. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02097.1998 · Cited by 171
Liang, F.-Q., Dejneka, N. S., Cohen, D. R., Krasnoperova, N. V., Lem, J., Maguire, A. M., Dudus, L., Fisher, K. J., & Bennett, J. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0252 · Cited by 167
[48] Production and purification of recombinant adeno-associated virus
Hauswirth, W. W., Lewin, A. S., Zolotukhin, S., & Muzyczka, N. (2000) · Methods in Enzymology · doi:10.1016/s0076-6879(00)16760-6 · Cited by 165
Self-citationRetinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2.
Lau, D., McGee, L. H., Zhou, S., Rendahl, K. G., Manning, W. C., Escobedo, J. A., & Flannery, J. G. (2000) · PubMed · Cited by 163
Baculoviral IAP Repeat-Containing-4 Protects Optic Nerve Axons in a Rat Glaucoma Model
McKinnon, S. J., Lehman, D. M., Tahzib, N. G., Ransom, N. L., Reitsamer, H. A., Liston, P., LaCasse, E., Li, Q., Korneluk, R. G., & Hauswirth, W. W. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0608 · Cited by 163
Self-citationPersistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV
Dudus, L., Anand, V., Acland, G. M., Chen, S.-J., Wilson, J. M., Fisher, K. J., Maguire, A. M., & Bennett, J. (1999) · Vision Research · doi:10.1016/s0042-6989(98)00308-3 · Cited by 160
Klein, R. L., Hamby, M. E., Gong, Y., Hirko, A. C., Wang, S., Hughes, J. A., King, M. A., & Meyer, E. M. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7942 · Cited by 160
Self-citationvon Bartheld, C. S., Williams, R., Lefcort, F., Clary, D. O., Reichardt, L. F., & Bothwell, M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-09-02995.1996 · Cited by 154
Ko, M., Hu, D., Ritch, R. H., Sharma, S. C., & Chen, C. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01830-4 · Cited by 151
Gene delivery to the eye using adeno-associated viral vectors
Martin, K. R. G., Klein, R. L., & Quigley, H. A. (2002) · Methods · doi:10.1016/s1046-2023(02)00232-3 · Cited by 149
Self-citationChauhan, B. C., Pan, J., Archibald, M. L., et al. (2002) · PubMed · Cited by 131
Jomary, C., Vincent, K. A., Grist, J., Neal, M., & Jones, S. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300440 · Cited by 130
Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer
Klein, R. L., Lewis, M. H., Muzyczka, N., & Meyer, E. M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02116-2 · Cited by 128
Self-citationWeibel, D., Kreutzberg, G. W., & Schwab, M. E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00238-l · Cited by 121
Guy, J. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.7.929 · Cited by 114
Descending optic nerve degeneration in primates.
Quigley, H. A., Davis, E. B., & Anderson, D. R. (1977) · PubMed · Cited by 104
Self-citationPotential Neuroprotective Therapy for Glaucomatous Optic Neuropathy
Yoles, E., & Schwartz, M. (1998) · Survey of Ophthalmology · doi:10.1016/s0039-6257(97)00123-9 · Cited by 100
Potential treatment modalities for glaucomatous neuropathy: neuroprotection and neuroregeneration.
Schwartz, M., Belkin, M., Yoles, E., et al. (1996) · PubMed · Cited by 94
Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina
Grant, C. A., Ponnazhagan, S., Wang, X.-S., Srivastava, A., & Li, T. (1997) · Current Eye Research · doi:10.1076/ceyr.16.9.949.5046 · Cited by 86
Klein, R. L., Muir, D. F., King, M. A., Peel, A. L., Zolotukhin, S., Möller, J. C., Krüttgen, A., Heymach, J. V., Muzyczka, N., & Meyer, E. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00537-5 · Cited by 85
Self-citationRescue of axotomized retinal ganglion cells by BDNF gene electroporation in adult rats.
Mo, X., Yokoyama, A., Oshitari, T., Negishi, H., Dezawa, M., Mizota, A., & Adachi‐Usami, E. (2002) · PubMed · Cited by 72
Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma.
Morrison, J. C., Nylander, K. B., Lauer, A. K., et al. (1998) · PubMed · Cited by 67
Bodeutsch, N., & Thanos, S. (2000) · Glia · doi:10.1002/1098-1136(200010)32:1<91::aid-glia90>3.0.co;2-x · Cited by 66
S∅rensen, J. C., Dalmau, I., Zimmer, J., & Finsen, B. R. (1996) · Experimental Brain Research · doi:10.1007/bf00227639 · Cited by 50
Neuroprotection of the optic nerve in glaucoma
Caprioli, J. (1997) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.1997.tb00391.x · Cited by 48
Histomorphometric Analysis of Optic Nerve Changes in Experimental Glaucoma
cel, Y. H. Y., KALICHMAN, M. W., Mizisin, A. P., Powell, H. C., & Weinreb, R. N. (1999) · Journal of Glaucoma · doi:10.1097/00061198-199902000-00009 · Cited by 46
Takano, M., Horie, H., Iijima, Y., Dezawa, M., Sawada, H., & Ishikawa, Y. (2002) · Experimental Eye Research · doi:10.1006/exer.2001.1118 · Cited by 44
Risk Factors in Ocular Hypertension
Georgopoulos, G., Andreanos, D., Liokis, N., Papakonstantinou, D., Vergados, J., & THEODOSSIADIS, G. P. (1997) · European Journal of Ophthalmology · doi:10.1177/112067219700700409 · Cited by 41
Survival of axotomized retinal ganglion cells in adult mammals.
Watanabe, M., Sawai, H., & Fukuda, Y. (1997) · PubMed · Cited by 41
Expression of Myocilin/TIGR in Normal and Glaucomatous Primate Optic Nerves
Ricard, C. S., Agapova, O. A., Salvador‐Silva, M., et al. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1063 · Cited by 34
The risk profile of the glaucomatous patient
Gramer, E., & Tausch, M. (1995) · Current Opinion in Ophthalmology · doi:10.1097/00055735-199504000-00013 · Cited by 26
Sj, C., & Ritch, R. H. (1997) · PubMed · Cited by 22
Retinal gene therapy 1998: summary of a workshop.
Hauswirth, W., & Rr, M. (1998) · PubMed · Cited by 17
Self-citation
Cited by
Quigley, H. A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61423-7 · Cited by 1,121
Self-citationThe molecular basis of retinal ganglion cell death in glaucoma
Almasieh, M., Wilson, A. M., Morquette, B., Cueva Vargas, J. L., & Di Polo, A. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.002 · Cited by 971
Bi, A., Cui, J., Ma, Y.-P., Olshevskaya, E., Pu, M., Dizhoor, A. M., & Pan, Z.-H. (2006) · Neuron · doi:10.1016/j.neuron.2006.02.026 · Cited by 771
Weinreb, R. N., Leung, C. K. S., Crowston, J. G., Medeiros, F. A., Friedman, D. S., Wiggs, J. L., & Martin, K. R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.67 · Cited by 632
Self-citationCuenca, N., Fernández-Sánchez, L., Campello, L., Maneu, V., De la Villa, P., Lax, P., & Pinilla, I. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.07.001 · Cited by 401
Metadata
- Authors
- Martin, K. R. G., Quigley, H. A., Zack, D. J., Levkovitch-Verbin, H., Kielczewski, J., Valenta, D., Baumrind, L., Pease, M. E., Klein, R. L., & Hauswirth, W. W.
- Affiliations
- Johns Hopkins University (US)
- Departments of Pharmacology and Therapeutics and
- University of Florida (US)
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2003-10-01
- Volume
- 44
- Issue
- 10
- Pages
- 4357
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2157252223
- Cited by
- 362
- References
- 68
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 10 · 2023: 10 · 2022: 15 · 2021: 14 · 2020: 18 · 2019: 12 · 2018: 14 · 2017: 14 · 2016: 24 · 2015: 27 · 2014: 16 · 2013: 15 · 2012: 8
- FWCI
- 13.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (#EY01765, EY 02120, P30EY001765)
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- gene therapy, brain-derived neurotrophic factor, retinal ganglion cells, glaucoma, adeno-associated virus vectors, neuroprotection, axonal loss, intraocular pressure elevation, laser-induced glaucoma, neurotrophic therapy
- MeSH terms
- Dependovirus, Animals, Axons, Cell Count, Cell Survival, Disease Models, Animal, Genetic Vectors, Glaucoma, Intraocular Pressure, Luminescent Proteins, Optic Nerve Diseases, Retinal Ganglion Cells, Blotting, Western, Genetic Therapy, Rats, Wistar, Gene Transfer Techniques, Brain-Derived Neurotrophic Factor, Cytoprotection, Green Fluorescent Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.